Skip to main content
XORTX Therapeutics Inc. logo

XORTX Therapeutics Inc. — Investor Relations & Filings

Ticker · XRTX ISIN · CA98420Q2071 LEI · 254900RAT3XZPF9F9350 US Manufacturing
Open in API
Filings indexed 263 across all filing types
Latest filing 2025-05-19 Regulatory Filings
Country CA Canada
Listing US XRTX

About XORTX Therapeutics Inc.

https://www.xortx.com/

XORTX Therapeutics Inc. is a late-stage clinical biopharmaceutical company that develops and commercializes therapies for diseases associated with aberrant purine metabolism and high serum uric acid. The company's pipeline focuses on progressive kidney diseases, including Autosomal Dominant Polycystic Kidney Disease (ADPKD), Type 2 Diabetic Nephropathy (T2DN), and Acute Kidney Injury (AKI), as well as gout. Its lead program, XRx-008, is in development for the treatment of ADPKD.

Recent filings

Filing Released Lang Actions
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filing, which is a report of a foreign private issuer submitted to the SEC under the Securities Exchange Act of 1934. It includes a signature from the CEO and references an attached press release (Exhibit 99.1). The document length is short (1211 characters) and primarily serves as a notification of the press release rather than containing substantive financial data or detailed report content. There is no indication of full financial statements, audit information, or detailed management discussion. According to the rules, such short filings that mainly announce or attach other documents are classified as Regulatory Filings (RNS).
2025-05-19 English
FORM 6-K
Interim / Quarterly Report Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, XORTX Therapeutics Inc., pursuant to SEC rules. It includes an exhibit index listing condensed interim consolidated financial statements and management discussion and analysis for the three months ended March 31, 2025, along with CEO and CFO certificates. Form 6-K filings typically provide interim or quarterly financial information for foreign issuers. The presence of condensed interim financial statements and MD&A indicates this is an Interim / Quarterly Report. The document length is short (1272 characters), but it contains substantive financial data references, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2025-05-16 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-05-15 English
20-F
Annual Report FY 2024
2025-05-09 English
NT 20-F
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the company, XORTX Therapeutics Inc., is notifying the SEC of a delay in filing its Annual Report on Form 20-F for the year ended December 31, 2024. The document explains the reason for the delay and the expected filing date. It does not contain the actual Annual Report (Form 20-F) itself, nor does it include financial data or analysis. The document is short (4166 characters) and serves as an announcement of a report delay rather than the report itself. According to the rules, such a notification is classified as a Regulatory Filing (RNS) because it is a compliance document notifying the SEC of a late filing, not the report itself.
2025-05-01 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes a press release as an exhibit but does not contain detailed financial statements or substantive financial data. The document length is short (1221 characters), and it primarily serves as a regulatory filing to disclose information to the SEC and the public. It does not represent an annual report, interim report, earnings release, or any other detailed financial or management report. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories.
2025-04-30 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.